Abstract:Chronic activation of the immune system in HIV infection is one of the strongest predictors of morbidity and mortality. As such, approaches that reduce immune activation have received considerable interest. Previously, we demonstrated that administration of a type I interferon receptor antagonist (IFN-1ant) during acute SIV infection of rhesus macaques results in increased virus replication and accelerated disease progression. Here, we administered a long half-life PASylated IFN-1ant to ART-treated and ART-naïve macaques during chronic SIV infection and measured expression of interferon stimulated genes (ISG) by RNA sequencing, plasma viremia, plasma cytokines, T cell activation and exhaustion as well as cell-associated virus in CD4 T cell subsets sorted from peripheral blood and lymph nodes. Our study shows that IFN-1ant administration in both ART-suppressed and ART-untreated chronically SIV-infected animals successfully results in reduction of IFN-I-mediated inflammation as defined by reduced expression of ISGs but had no effect on plasma levels of IL-1β, IL-1ra, IL-6 and IL-8. Unlike in acute SIV infection, we observed no significant increase in plasma viremia up to 25 weeks after IFN-1ant administration or up to 15 weeks after ART interruption. Likewise, cell-associated virus measured by SIV gag DNA copies was similar between IFN-1ant and placebo groups. In addition, evaluation of T cell activation and exhaustion by surface expression of CD38, HLA-DR, Ki67, LAG-3, PD-1 and TIGIT, as well as transcriptome analysis showed no effect of IFN-I blockade. Thus, our data show that blocking IFN-I signaling during chronic SIV infection suppresses IFN-I-related inflammatory pathways without increasing virus replication, and thus may constitute a safe therapeutic intervention in chronic HIV infection.

Type I Interferons Suppress Viral Replication but Contribute to T Cell Depletion and Dysfunction During Chronic HIV-1 Infection

Blockade of Type I Interferon Signaling Reverses HIV-1 Induced Immune Dysfunction and Reduces HIV-1 Reservoirs

Blocking Type I Interferon Signaling Enhances T Cell Recovery and Reduces HIV-1 Reservoirs.

Targeting type I interferon–mediated activation restores immune function in chronic HIV infection

Pathogenic Role of Type I Interferons in HIV-Induced Immune Impairments in Humanized Mice

Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication

Type I Interferon Responses by HIV-1 Infection: Association with Disease Progression and Control

Infection and Depletion of CD4+ Group-1 Innate Lymphoid Cells by HIV-1 Via Type-I Interferon Pathway.

The Significance of Type-I Interferons in the Pathogenesis and Therapy of Human Immunodeficiency Virus 1 Infection

Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment

Type I Interferon Protects Antiviral CD8+ T Cells from NK Cell Cytotoxicity

Interferon-α inhibits CD4 T cell responses to interleukin-7 and interleukin-2 and selectively interferes with Akt signaling

Type I Interferons and TGF-β Cooperate to Induce Liver Fibrosis During HIV-1 Infection under Antiretroviral Therapy.

A Commentary of “type I Interferon Deficiency Can Lead to Severe COVID-19” in 10 Remarkable Discoveries from 2020 in Nature

Antithetic effect of interferon-α on cell-free and cell-to-cell HIV-1 infection

Type I interferons in infectious disease

Plasmacytoid Dendritic Cells Suppress Hiv-1 Replication but Contribute to Hiv-1 Induced Immunopathogenesis in Humanized Mice

Type I Interferons and Interferon Regulatory Factors Regulate TNF-Related Apoptosis-Inducing Ligand (TRAIL) in HIV-1-Infected Macrophages

Type I Interferon in Chronic Virus Infection and Cancer

Type 1 interferon-induced IL-7 maintains CD8+ T-cell responses and homeostasis by suppressing PD-1 expression in viral hepatitis

Plasmacytoid Dendritic Cells Impair HIV-specific CD8 T Cells to Maintain HIV-1 Reservoir Persistence During Chronic HIV Infection under Cart